Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Common Equity: 2021-2025

Historic Common Equity for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $66,719.

  • ProQR Therapeutics N.V's Common Equity rose 143.18% to $66,719 in Q3 2025 from the same period last year, while for Sep 2025 it was $66,719, marking a year-over-year increase of 143.18%. This contributed to the annual value of $94.6 million for FY2024, which is 111.37% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Common Equity of $66,719 as of Q3 2025, which was down 12.01% from $75,822 recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Common Equity peaked at $151.7 million during Q3 2021, and registered a low of $27,436 during Q3 2024.
  • Over the past 3 years, ProQR Therapeutics N.V's median Common Equity value was $83,030 (recorded in 2025), while the average stood at $19.6 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 188,527.86% in 2022, then crashed by 99.95% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Common Equity stood at $130.5 million in 2021, then plummeted by 47.88% to $68.0 million in 2022, then crashed by 34.54% to $44.5 million in 2023, then slumped by 99.79% to $94,635 in 2024, then soared by 143.18% to $66,719 in 2025.
  • Its last three reported values are $66,719 in Q3 2025, $75,822 for Q2 2025, and $83,030 during Q1 2025.